INFECTION-ASSOCIATED DEMENTIA

Herpan Syafii Harahap, Sri Budhi Rianawati
  MNJ, pp. 28-35  

Abstract


Central nervous system infection may decrease cognitive function in broad spectrum, ranged from mild cognitive impairment to infection-associated dementia. Infection-associated dementia is a dementia which develops concomitantly or lately after central nervous system infection by any microorganism. Some study showed infection-associated dementia was likely developing as the secondary neuronal response to the activation of immune cell in the brain activated by infectious agent. Screening and formal neuropsyichological testing are the most important examination modalities for the diagnosis of infection associated dementia. The availability of functional radiological examination techniques are useful for identifying of brain function and visualizing the brain activities in vivo. The recent modality treatments for infection-associated dementia are insignificantly different with the modality treatments for other dementia. These treatment are consists of pharmacological and non-pharmacological treatments.


Keywords


infection-associated dementia; inflammaatory process; neurodegeneration; neuropsychological tests

Full Text:

PDF

References


Chan LG, Kandiah N, Chua A. HIV-associated neurocognitive disorders (HAND) in a South Asian population - contextual application of the 2007 criteria. BMJ Open 2012;2:e000662.

Robbins RN, et al. Screening for HIV-Associated Dementia in South Africa: Potentials and Pitfalls of Task-Shifting. AIDS PATIENT CARE and STDs 2011; 25(10):587-592.

Ghafouri M, Amini S, Khalili K, Sawaya BE. HIV1 associated dementia: symptoms and causes. Retrovirology 2006; 3:28-39.

Almeida OP, Lautenschlager NT. Dementia associated with infectious disease. Int Psychogeriatr 2005;17(1):65-77.

Wang T, Rumbaugh JA, Nath A. Viruses and the brain: from inflammation to dementia. Clinical Science 2006;110: 393–407.

Sadock BJ, Sadock VA. 2007. Kaplan and Sadock’s Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Tenth edition. USA: Lippincott Williams and Wilkins. p330338.

Griffin PT, Gerhardstein K. Cognitive testing in HIV/AIDS: A case for early assessment. Fall 2010;22(4):6-9.

Feldman HH, et al. Diagnosis and treatment of dementia: diagnosis. CMAJ 2008;178(7): 825835.

Roos KL, et al. 2005. Principles of Neurologic Infectious Disease. USA: The McGraw-Hill Companies, Inc. p113-130.

WHO. 2011. Global HIV/AIDS Response: Epidemic update and health sector progress toward Universal Access. Progress Report 2011.

Duarte AG, Cikurel K, Simpson DM. Selected Neurologic Complications of HIV and Antiretroviral Therapy. The PRN Notebook 2006; 11(2): 24-29.

Carter CJ. Alzheimer’s Disease: A Pathogenetic Autoimmune Disorder Caused by Herpes Simplex in a Gene-Dependent Manner. International Journal of Alzheimer’s Disease 2010;10:1-17.

Imran M, Mahmood S. An overview of human prion diseases. Virology Journal 2011;8:559.

Idro R, Jenkins NE, Newton NE. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005;4:827840.

Suzuki Y, Halonen S, Wang X, Wen X. 2007. Cerebral Toxoplasmosis: Pathogenesis and Host Resistance. In: Toxoplasma gondii. First edition. London: Elsevier. p 567-582.

Kasper LH. 2008. Toxoplasma Infection. In: Harrison’s Principles of Internal Medicine. 17th edition. USA: McGraw-Hill Companies, Inc. p.1305-1308.

Gigley JP, Bhadra R, Khan IA. CD8 T cells and Toxoplasma gondii: a new paradigm. Journal of Parasitology Research 2011. pp1-9.

Miklossy J. 2008. Biology and neuropathology of dementia in syphilis and Lyme disease. In: Handbook of Neurology. USA: Elsevier B. V. p825-840.

Kovacs GG, Budka H. Molecular Pathology of Human Prion Diseases. Int. J. Mol. Sci. 2009;10: 76-999.

Jayawardena S, Singh S, Burzyantseva O, Clarke H. Cerebral toxoplasmosis in adult patients with HIV infection. Hospital Physician 2008.pp 17-24.

Kim SK, Karasov A, Boothroyd JC. Bradyzoitespecific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in

the brain and in host control of parasite replication in the intestine. Infection and Immunity 2007; 75(4): 1626-1634.

Randall LM, Hunter CA. Parasite dissemination and the pathogenesis of toxoplasmosis. European Journal of Microbiology and Immunology 1 2011;1:3-9.

Hagberg L, et al. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Research and Therapy 2010; 7(1): 15.

Garsten M, et al. An Integrated Systems Analysis Implicates EGR1 Downregulation in Simian Immunodeficiency Virus Encephalitis Induced Neural Dysfunction. J Neurosci 2009; 29(40):12467–12476.

Williams R, et al. Pro-inflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes. Glia 2009; 57(7): 734–743.

Lindl KA, et al. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J Neuroimmune Pharmacol 2010; 5(3):294-309.

Ellis R. HIV and antiretroviral therapy: impact on the central nervous system. Prog Neurobiol 2010; 91(2): 185-187.

Giunta B, et al. HIV-1 TAT Inhibits Microglial Phagocytosis of Aβ Peptide. Int J Clin Exp Pathol 2008;1: 260-275.

Schouten J, et al. HIV-1 infection and cognitive impairment in the cART-era: a review. AIDS 2011;25:1-16.

Lawler K, et al. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J International AIDS Society 2010;13:15.

Campbell WW. 2013. DeJong's The Neurologic Examination. 6th Edition. USA: Lippincott Williams and Wilkins. p75-84.

Lopes M, Brucki SMD, Giampaoli V, Mansur LL. Semantic Verbal Fluency test in dementia: preliminary retrospective analysis. Dement Neuropsychol 2009;3(4):315-320.

Valcour V, et al. Screening for Cognitive Impairment in Human Immunodeficiency Virus. CID 2011;53(8): 836-842.

Robertson K, Liner J, Heaton R. Neuropsychological Assessment of HIV Infected Populations in International Settings. Neuropsychol Rev 2009; 19:232–249.

Pokdi Fungsi Luhur. 2010. Panduan Pemeriksaan Neurologi dan Neurobehavior. Jakarta: PERDOSSI.

Humpel C. Identifying and validating biomarkers for Alzheimer’s disease. Trends in Biotechnology 2011;29(1):20-31.

Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 2009;19:152-168.

SIGN. 2006. Management of patients with dementia. Edinburgh: Scottish Intercollegiate Guidelines Network. p7-20.

Qaseem A, et al. Guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2008;148:370-378.


Refbacks

  • There are currently no refbacks.